Retinal biomarkers for neurodegenerative disease
Eye-scanning technologies that detect Alzheimer's and other neurodegenerative disease biomarkers directly in the retina — a window onto brain pathology accessible without imaging the brain itself.
How it works
This is a procurement category, not a named manufacturer's product. As a paid service, Bioecon finds suppliers for your task, agrees configuration and specification, and arranges supply; the price is on request. Bioecon may receive a fee from suppliers — this is disclosed and does not affect the portal's grades or lists.
Technology
Retinal biomarkers for neurodegenerative disease — Evidence, registration route, funding and suppliers are on the technology page.
Eye-scan technologies that detect Alzheimer's and other neurodegenerative-disease biomarkers directly in the retina — a window onto brain pathology accessible without imaging the brain itself — spanning hyperspectral imaging, OCT-based structural biomarkers and retinal amyloid detection: RetiSpec …
Links
- Import and registration route
- CHEM — Minpromtorg (registration) / Rospotrebnadzor (notification of …
- Capabilities
- Testing & analytics
Related items
Other categories for this technology
Analytical & testing services · Laboratory & analytical instruments · Regulatory & certification
In the same node
Base editing · Bioelectronics experiment kits · Bioluminescence & marine fluorescent proteins · Breath-based diagnostics (breathomics) · Companion diagnostics platforms · CRISPR diagnostics · CRISPR educational kits · CRISPR screening as a service · All →